Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 17, 2026

Tide Unveils World-First Laundry Breakthrough: Introducing Tide evo, the Fiber-Detergent Tile

View original at finance.yahoo.com
Tide Unveils World-First Laundry Breakthrough: Introducing Tide evo, the Fiber-Detergent Tile First-of-its-Kind Technology, Tide evo Delivers a Breakthrough Clean so Powerful, it’s Like Magic CINCINNATI, February 17, 2026--(BUSINESS WIRE)--Tide®, America’s #1 trusted laundry detergent brand, continues to deliver an unm…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • U.S. laundry care market size was estimated at $24.87 billion in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2030

    80% confidence

  • Tide brand aims to turn three out of four laundry loads in the U.S. and Canada to cold by 2030

    80% confidence

  • Tide evo redefines the laundry category while addressing modern consumers' wants from a detergent. It's lighter, faster, simpler, and provides a superior clean

    80% confidence

  • Tide evo represents over ten years of innovation and product development, and showcases Tide's journey of reinvention every decade: from soap to detergent, powder to liquid then PODs, and now, laundry tiles

    80% confidence

  • Consumers who have used Tide evo describe the experience as 'new, different, and innovative,' with some describing that it provides a clean so unbelievable, it's 'like real laundry magic'

    80% confidence

Data points we hold from this source

Procter & Gamble · countries of operation70 countries
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Tide Unveils World-First Laundry Breakthrough: Introducing Tide evo, the Fiber-Detergent Tile — Source | Via News | ViaNews EU